» Articles » PMID: 11505460

Immunogenic and Isotype-specific Responses to Russian and US Cold-adapted Influenza a Vaccine Donor Strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in Mice

Overview
Journal J Med Virol
Specialty Microbiology
Date 2001 Aug 16
PMID 11505460
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The immunogenicity of the Russian cold-adapted (ca) donor stains, A/Leningrad (Len)/134/17/57 and A/Leningrad/134/47/57, and the US strain A/Ann Arbor (AA)/6/60-ca, were compared in BALB/c mice with their respective wild-type parental viruses. Each ca donor strain was less immunogenic than its wild-type parent. The vaccinating dose, when administered twice, which prevented multiplication of a standard challenge of parental wild-type virus in 50% of mice (the 50% protective dose or PD(50)), was shown for A/Len/134/17/57-ca, A/Len/134/47/57-ca, and A/AA/6/60-ca to be 10(3.77), 10(4.32), and 10(4.70), respectively. These findings were extended by measuring the number of antibody secreting cells induced in the lungs and mediastinal lymph nodes of mice infected with the same ca donors using an ELISPOT assay. When each donor strain was administered twice at a dose of 100 PD(50) over a 3-week interval, the overall immunoglobulin isotype antibody secreting cell profiles were shown to be similar. However, A/Len/134/17/57-ca and A/Len/134/47/57-ca induced significantly higher total immunoglobulin responses in the lungs than A/AA/6/60-ca (P < 0.05). A/Len/134/17/57-ca also induced a significantly greater IgA response in the lungs than A/AA/6/60-ca (P < 0.05). These results suggest that A/Len/134/17/57-ca is a superior immunogen to A/Len/134/47/57-ca which in turn is more immunogenic than A/AA/6/60-ca.

Citing Articles

Generation of a recombinant temperature-sensitive influenza D virus.

Ishida H, Murakami S, Kamiki H, Matsugo H, Katayama M, Sekine W Sci Rep. 2023; 13(1):3806.

PMID: 36882459 PMC: 9992382. DOI: 10.1038/s41598-023-30942-z.


Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets.

Luczo J, Bousse T, Johnson S, Jones C, Pearce N, Neiswanger C NPJ Vaccines. 2021; 6(1):59.

PMID: 33883559 PMC: 8060263. DOI: 10.1038/s41541-021-00320-9.


Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature.

Liu Z, Geng X, Cui Z, Li W, Ou X, Liao G J Cell Mol Med. 2020; 24(19):11198-11210.

PMID: 32902192 PMC: 7576294. DOI: 10.1111/jcmm.15672.


Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site.

Kotomina T, Korenkov D, Matyushenko V, Prokopenko P, Rudenko L, Isakova-Sivak I Hum Vaccin Immunother. 2018; 14(12):2964-2970.

PMID: 30024831 PMC: 6343631. DOI: 10.1080/21645515.2018.1502529.


Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

Isakova-Sivak I, de Jonge J, Smolonogina T, Rekstin A, van Amerongen G, van Dijken H PLoS One. 2014; 9(7):e102339.

PMID: 25058039 PMC: 4109939. DOI: 10.1371/journal.pone.0102339.